Kelsi B. Holland

<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Guido Marcucci, Kati Maharry, Yue-Zhong Wu et al. · Journal of Clinical Oncology · 2010 · 764 citations · Full text

Medicine, Hematology, Oncology +17

<i>TET2</i> Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Klaus H. Metzeler, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2011 · 320 citations · Full text

Medicine, Molecular Genetics, Oncology +17

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Susan P. Whitman, Kati Maharry, Michael D. Radmacher et al. · Blood · 2010 · 230 citations · Full text

Life Sciences, Genetics, Oncology +16

Prognostic Significance of Expression of a Single MicroRNA, <i>miR-181a</i>, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Sebastian Schwind, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2010 · 180 citations

Medicine, Hematology, Oncology +17

Prognostic Importance of <i>MN1</i> Transcript Levels, and Biologic Insights From <i>MN1</i>-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Christian Langer, Guido Marcucci, Kelsi B. Holland et al. · Journal of Clinical Oncology · 2009 · 151 citations · Full text

Life Sciences, Molecular Biology, Oncology +17